These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4848874)

  • 21. Essential thrombocythemia after treatment of non-Hodgkin's lymphoma.
    Maciel JF; de Lourdes Chauffaille M; Inaoka RJ; Colleoni GW; Yamamoto M
    Leuk Res; 2007 Nov; 31(11):1593-5. PubMed ID: 17324461
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug therapy of Hodgkin's disease].
    Gallmeier WM; Bruntsch U
    Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
    [No Abstract]   [Full Text] [Related]  

  • 23. The therapy of Hodgkin's disease in Nigeria: a five year study.
    Oluboyede OA; Esan GJ
    Afr J Med Med Sci; 1976 Sep; 5(3):201-7. PubMed ID: 829730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes of serum amino acids during polychemotherapy in Hodgkin's disease].
    Tilz GP; Stübchen-Kirchner H; Sailer S
    Wien Med Wochenschr; 1974 Oct; 124(42-43):617-9. PubMed ID: 4439956
    [No Abstract]   [Full Text] [Related]  

  • 25. [Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease].
    Kumagai K; Takagi T; Sakai C; Wakatsuki S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):499-501. PubMed ID: 8678506
    [No Abstract]   [Full Text] [Related]  

  • 26. [Unusually long survival times in patients with advanced Hodgkin's disease (author's transl)].
    Hiller E; Wilmanns W; Wilms K
    Klin Wochenschr; 1979 Jul; 57(14):747-8. PubMed ID: 470336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Status and perspectives in chemotherapy of Hodgkin's disease.
    Frei E
    Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
    [No Abstract]   [Full Text] [Related]  

  • 28. [Combination chemotherapy of advanced Hodgkin's disease with vincristine, cyclophosphamide, procarbazine, and prednisolone].
    Mizunuma N; Ogawa M; Kuraishi Y; Horikoshi N; Inoue K; Mukaiyama T; Fukutani H; Tabata M; Hirano A; Itami S
    Rinsho Ketsueki; 1991 Nov; 32(11):1410-5. PubMed ID: 1758048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
    J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO
    Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
    [No Abstract]   [Full Text] [Related]  

  • 31. [Functional state of the liver in lymphogranulomatosis during drug and radiation treatment].
    Danova LA; Filov VA
    Vopr Onkol; 1972; 18(10):43-7. PubMed ID: 4662532
    [No Abstract]   [Full Text] [Related]  

  • 32. Fetal renal malformation following treatment of Hodgkin's disease during pregnancy.
    Mennuti MT; Shepard TH; Mellman WJ
    Obstet Gynecol; 1975 Aug; 46(2):194-6. PubMed ID: 1153150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute myeloid leukemia six years after chemotherapy of Hodgkin's disease].
    Fujii H; Yashige H; Maekawa T; Horiike S
    Rinsho Ketsueki; 1988 Dec; 29(12):2369-74. PubMed ID: 3246723
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
    Neumann E
    Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    DeVita VT
    Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
    [No Abstract]   [Full Text] [Related]  

  • 36. Single-agent therapy for Hodgkin's disease.
    Carter SK; Livingston RB
    Arch Intern Med; 1973 Mar; 131(3):377-87. PubMed ID: 4631683
    [No Abstract]   [Full Text] [Related]  

  • 37. [Leukemia in Hodgkin's disease due to cancerostatic therapy?].
    Schaefer UW; Kanzler G
    Med Klin; 1972 Aug; 67(31):1024-8. PubMed ID: 4506640
    [No Abstract]   [Full Text] [Related]  

  • 38. Fatal strongyloidiasis in Hodgkin's disease after immunosuppressive therapy.
    Yim Y; Kikkawa Y; Tanowitz H; Wittner M
    J Trop Med Hyg; 1970 Oct; 73(10):245-9. PubMed ID: 5312266
    [No Abstract]   [Full Text] [Related]  

  • 39. [After-care examinations in Hodgkin's disease. Internal medicine and chemotherapy].
    Deutsch E; Honetz N
    Fortschr Geb Rontgenstr Nuklearmed; 1973; 0(0):suppl:120-3. PubMed ID: 4135457
    [No Abstract]   [Full Text] [Related]  

  • 40. Greater curability in advanced Hodgkin's disease?
    Portlock CS
    Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.